VZ vs T: What's the Better Long-Term Play? — Negative

T  VZ   The Motley Fool — December 21, 2025

AT&T cut its dividend in 2022, and its stock performance has remained flat since. Verizon has increased its dividend for 19 consecutive years, but the stock has struggled in the past five years.

image for news VZ vs T: What's the Better Long-Term Play?

Visa and Mastercard Settle ATM Fee Lawsuit for $167 Million — Negative

MA   PYMNTS — December 21, 2025

Visa and Mastercard will reportedly pay $167.5 million to settle a long-running ATM fee lawsuit. That's according to a report Friday (Dec. 19) from Reuters, citing court documents in a case that had accused the payment giants of conspiring to artificially boost ATM access fees.

image for news Visa and Mastercard Settle ATM Fee Lawsuit for $167 Million

Gold Edges Higher Amid Geopolitical Tensions — Positive

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  UGL   WSJ — December 21, 2025

Gold edged higher in the morning Asian session amid geopolitical tensions that typically enhance the safe-haven allure of the precious metal.

image for news Gold Edges Higher Amid Geopolitical Tensions

iRobot filed for bankruptcy and will be acquired by Picea Robotics, a Chinese company. Founder Colin Angle said iRobot faced rising competition from Chinese robotics firms.

image for news iRobot founder says company's bankruptcy revealed a new kind of competitor: 'The Chinese fast follower'

Prediction markets are ‘best we've got' for forecasting, Robinhood CEO says — Positive

HOOD   Fox Business — December 21, 2025

Robinhood Markets CEO Vlad Tenev explains how prediction markets have become the ‘fastest growing business of all time' and discusses their future on ‘Making Money.' #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #makingmoney #robinhood #vladtenev #predictionmarkets #markets #stocks #finance #business #economy #trading #forecasting #tech #innovation #growth #analysis

image for news Prediction markets are ‘best we've got' for forecasting, Robinhood CEO says

VOO charges much lower fees and offers a higher dividend yield compared to QQQ. QQQ has delivered stronger five-year growth but with higher volatility and a deeper drawdown.

image for news VOO vs. QQQ: Is S&P 500 Stability or Tech-Focused Growth the Better Choice for Investors?

VYM vs. FDVV: How These Popular Dividend ETFs Stack Up on Yield, Costs, and Risk — Positive

FDVV  VYM   The Motley Fool — December 21, 2025

VYM costs less and holds a much broader basket of stocks than FDVV. FDVV delivers a higher dividend yield and is more concentrated in technology.

image for news VYM vs. FDVV: How These Popular Dividend ETFs Stack Up on Yield, Costs, and Risk

South Korea's Samsung Biologics said on Monday its U.S. unit is buying a U.S. drug production facility from GSK for $280 million.

image for news Samsung Biologics to buy U.S. drug production facility from GSK for $280 mln

Could This AI Leader Be the Market's Best Performer Next Year? — Positive

MU   The Motley Fool — December 21, 2025

Micron just reported another strong quarter of sales and earnings growth. The company benefits from increasing demand for its DRAM memory.

image for news Could This AI Leader Be the Market's Best Performer Next Year?

Secures the company's first U.S.-based manufacturing site, strengthening and diversifying its global supply network Additional investments planned to expand the site's capacity (currently at 60,000 liters of drug substance) and capabilities to support growing manufacturing programs Underscores Samsung Biologics' long-term dedication to the U.S. biopharmaceutical industry and supply chain INCHEON, South Korea, ROCKVILLE, Md. and LONDON , Dec. 21, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced that its wholly owned U.S. subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100% of Human Genome Sciences from GSK …

image for news Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK

Alphabet vs. Amazon: Which Stock Will Outperform in 2026? — Positive

AMZN  GOOG  GOOGL   The Motley Fool — December 21, 2025

Alphabet was able to change investor perception in 2025, leading to huge gains in the stock. Amazon has the same opportunity to do that in 2026.

image for news Alphabet vs. Amazon: Which Stock Will Outperform in 2026?

U.S. Coast Guard Chasing Another Tanker Involved in Shipping Venezuela Oil — Negative

BNO  DBO  GUSH  IEO  OIH  OIL  PXJ  UCO  USO  XOP   WSJ — December 21, 2025

The operation comes after the boarding of two other ships this month as the administration carries out Trump's order to blockade Venezuela's oil shipments

image for news U.S. Coast Guard Chasing Another Tanker Involved in Shipping Venezuela Oil

Is LULU Stock a Buy After the CEO Announced His Resignation? — Negative

LULU   The Motley Fool — December 21, 2025

Lululemon stock is down more than 40% in the past five years. The brand's founder and former CEO, Chip Wilson, has been outspoken in his criticisms of company leadership and the board of directors.

image for news Is LULU Stock a Buy After the CEO Announced His Resignation?

VOOG has delivered higher one-year and five-year total returns, but with deeper drawdowns and more volatility than VOO. VOO is broader, more diversified, and offers a higher dividend yield at a lower expense ratio.

image for news VOO vs. VOOG: Is S&P 500 Diversification or Tech-Focused Growth the Better Choice for Investors?

TQQQ charges a slightly lower expense ratio, but it carries far more risk than SSO. TQQQ has delivered a marginally stronger one-year return, while also experiencing a significantly deeper five-year drawdown.

image for news TQQQ and SSO Aim for Above-Average Returns, But There's a Clear Winner for Investors

What's Going on With Oracle Stock? — Negative

ORCL   The Motley Fool — December 21, 2025

Oracle's (ORCL +6.63%) stock price is falling, and investors are curious about the causes.

image for news What's Going on With Oracle Stock?

MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides a precision medicine portfolio update in relation to:

image for news Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions

2 Monster Stocks to Hold for the Next 5 Years — Positive

BROS  NVDA   The Motley Fool — December 21, 2025

Nvidia has created a wide moat and is poised to continue to be one of the biggest AI winners over the next five years. Dutch Bros is one of the best growth stories in the consumer space.

image for news 2 Monster Stocks to Hold for the Next 5 Years

What's Going on With Costco Stock? — Negative

COST   The Motley Fool — December 21, 2025

Costco (COST 0.23%) stock is experiencing a rare underperformance in 2025.

image for news What's Going on With Costco Stock?

QLD has delivered a marginally higher one-year total return than SPXL, but both funds exhibit similar extreme drawdown risk. SPXL holds far more stocks, while QLD concentrates heavily in technology with just 101 positions.

image for news QLD vs. SPXL: Is Tech-Heavy Growth or S&P 500 Diversification Better for Investors?